search
Back to results

The Cognitive Resilience Study (CogRes)

Primary Purpose

Alzheimer Disease

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Cognitive stress tests during functional MRI
Cognitive stress tests during gait task
Sponsored by
Duke University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Alzheimer Disease

Eligibility Criteria

58 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Able to walk 2 minutes without assistive device or assistance from another person
  • Cognitive function within normal limits

Exclusion Criteria:

  • Unable to undergo MRI
  • Left handed
  • Red/Green Color Blind
  • Severe vision impairments
  • Diagnosis of Alzheimer's Disease or other dementia/memory problem

Sites / Locations

  • Duke University Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

High Risk Alzheimer's Disease

Low Risk Alzheimer Disease

Arm Description

This group includes subjects with APOEe4 homozygotes, the genetic profile associated with the highest risk for late-onset AD and the next highest-risk group, APOE e3/e4 heterozygotes. To target the highest risk among the APOEe3/e4 heterozygotes in ADPR, the study team will consider TOMM40-'523 variant status. Although there is uncertainty about the independent role of TOMM40 in AD risk-stratification (especially across racial/ethnic groups), this study will use TOMM40-'523 to guide heterozygote selection based on findings that among e3/e4 heterozygotes, longer TOMM40-523 polyT sequences are associated with earlier age of onset for late-onset AD.

This group includes e2/e2 homozygotes (rare) and e2/e3 heterozygotes. the genetic profile associated with low risk for late-onset development of Alzheimer's disease.

Outcomes

Primary Outcome Measures

Change in reaction time during memory testing during fMRI
The primary dependent variable will be change in reaction time when comparing a neutral memory task to a stress condition. Reaction time will be in ms and will be recorded while the subject is undergoing fMRI.
Change in reaction time during executive function testing during fMRI
The primary dependent variable will be change in reaction time when comparing a neutral executive function task to a stress condition. Reaction time will be in ms and will be recorded while the subject is undergoing fMRI.
Change in accuracy during memory testing during gait task
The primary dependent variable will be DTEcog = (Dual task [cognitive score] - Single Task [cognitive score] / Single task [cognitive score]. For the memory task, the primary cognitive measure will be the number of correct responses.
Change in reaction time during executive function testing during gait task
The primary dependent variable will be DTEcog = (Dual task [cognitive score] - Single Task [cognitive score] / Single task [cognitive score]. For the executive task, the primary cognitive measure in the DTEcog calculation will be reaction time.

Secondary Outcome Measures

Change in accuracy during memory testing during fMRI
Secondary dependent variables are accuracy (% correct) when comparing a neutral memory task to a stress condition.
Change in accuracy during executive function testing during fMRI
Secondary dependent variables are accuracy (% correct) when comparing a neutral memory task to a stress condition.
Brain activation during memory testing during fMRI
Group differences in brain activation provoked by the memory stress condition will be assessed using brain maps that compare block-average BOLD signal for resting vs neutral task, resting vs stress task, neutral vs stress task.
Brain activation during executive function testing during fMRI
Group differences in brain activation provoked by the executive function stress condition will be assessed using brain maps that compare block-average BOLD signal for resting vs neutral task, resting vs stress task, neutral vs stress task.
Change in gait performance provoked by memory dual tasking
The secondary dependent variable will be DTEmob = (Dual task[mobility score] - Single Task[mobility score] / Single task [mobility score]. For both memory and executive tasks, the mobility measure in the DTEmob calculation will be gait speed.
Change in gait performance provoked by executive function dual tasking
The secondary dependent variable will be DTEmob = (Dual task[mobility score] - Single Task[mobility score] / Single task [mobility score]. For both memory and executive tasks, the mobility measure in the DTEmob calculation will be gait speed.

Full Information

First Posted
January 9, 2017
Last Updated
August 11, 2017
Sponsor
Duke University
Collaborators
National Institute on Aging (NIA), Bryan Alzheimer's Disease Research Center, Duke University Center for the Study of Aging and Human Development
search

1. Study Identification

Unique Protocol Identification Number
NCT03016702
Brief Title
The Cognitive Resilience Study
Acronym
CogRes
Official Title
The Cognitive Resilience Study: Stress Tests for Alzheimer's Disease
Study Type
Interventional

2. Study Status

Record Verification Date
December 2016
Overall Recruitment Status
Completed
Study Start Date
February 27, 2017 (Actual)
Primary Completion Date
August 9, 2017 (Actual)
Study Completion Date
August 9, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Duke University
Collaborators
National Institute on Aging (NIA), Bryan Alzheimer's Disease Research Center, Duke University Center for the Study of Aging and Human Development

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to test whether two new cognitive "stress tests" may help distinguish between people at lower or higher genetic risk of Alzheimer's Disease. The investigators are trying to understand how these cognitive "stress tests" work in people who have not been diagnosed with Alzheimer's Disease and are not exhibiting symptoms of Alzheimer's Disease. Study subjects will undergo testing of memory and executive function during functional magnetic resonance image (fMRI) of the brain and also during a walking test.
Detailed Description
The objective is to establish the feasibility and evaluate the role of two novel tests of cognitive resilience for use in identification of early Alzheimer's Disease. The investigators hypothesize that exposure to the controlled stressor of increased cognitive task demand will evoke measurable phenotypes of poor resilience, which will be associated with Alzheimer's Disease risk. The study will include 30 volunteer participants from the Duke Alzheimer's Disease Prevention Registry (ADPR). The ADPR cohort has been characterized according to genetic risk based on genotype at loci associated with Alzheimer's Disease. The investigators will recruit a sample from the ADPR that includes 15 people in the "genetic high risk" group and 15 people, matched by age, in the "genetic low risk" group. Investigators and experimenters are masked to the genetic profile of all participants. All participants will undergo two cognitive stress test protocols. Both protocols include memory and executive function components, one done during functional MRI and one while ambulating on a force sensor mat. Both cognitive stress tests are minimal risk; the primary risk of this study is loss of confidentiality. Genetic testing is not performed as part of this protocol; the sampling strategy will make use of prior genetic testing results, which are not revealed to the primary investigators. In addition to determining whether scores on the two novel tests statistically differ by AD risk groups, the project will establish the tests' feasibility and characteristics for use in future study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alzheimer Disease

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Non-Randomized
Enrollment
29 (Actual)

8. Arms, Groups, and Interventions

Arm Title
High Risk Alzheimer's Disease
Arm Type
Experimental
Arm Description
This group includes subjects with APOEe4 homozygotes, the genetic profile associated with the highest risk for late-onset AD and the next highest-risk group, APOE e3/e4 heterozygotes. To target the highest risk among the APOEe3/e4 heterozygotes in ADPR, the study team will consider TOMM40-'523 variant status. Although there is uncertainty about the independent role of TOMM40 in AD risk-stratification (especially across racial/ethnic groups), this study will use TOMM40-'523 to guide heterozygote selection based on findings that among e3/e4 heterozygotes, longer TOMM40-523 polyT sequences are associated with earlier age of onset for late-onset AD.
Arm Title
Low Risk Alzheimer Disease
Arm Type
Experimental
Arm Description
This group includes e2/e2 homozygotes (rare) and e2/e3 heterozygotes. the genetic profile associated with low risk for late-onset development of Alzheimer's disease.
Intervention Type
Other
Intervention Name(s)
Cognitive stress tests during functional MRI
Intervention Description
Subjects will undergo progressively more complex cognitive stress tests that assess memory and executive function while undergoing fMRI.
Intervention Type
Other
Intervention Name(s)
Cognitive stress tests during gait task
Intervention Description
Subjects will undergo progressively more complex cognitive stress tests that assess memory and executive function both in sitting and while ambulating on a force sensor mat.
Primary Outcome Measure Information:
Title
Change in reaction time during memory testing during fMRI
Description
The primary dependent variable will be change in reaction time when comparing a neutral memory task to a stress condition. Reaction time will be in ms and will be recorded while the subject is undergoing fMRI.
Time Frame
Measured immediately during one hour fMRI
Title
Change in reaction time during executive function testing during fMRI
Description
The primary dependent variable will be change in reaction time when comparing a neutral executive function task to a stress condition. Reaction time will be in ms and will be recorded while the subject is undergoing fMRI.
Time Frame
Measured immediately during one hour fMRI
Title
Change in accuracy during memory testing during gait task
Description
The primary dependent variable will be DTEcog = (Dual task [cognitive score] - Single Task [cognitive score] / Single task [cognitive score]. For the memory task, the primary cognitive measure will be the number of correct responses.
Time Frame
Measured immediately during one hour gait session
Title
Change in reaction time during executive function testing during gait task
Description
The primary dependent variable will be DTEcog = (Dual task [cognitive score] - Single Task [cognitive score] / Single task [cognitive score]. For the executive task, the primary cognitive measure in the DTEcog calculation will be reaction time.
Time Frame
Measured immediately during one hour gait session
Secondary Outcome Measure Information:
Title
Change in accuracy during memory testing during fMRI
Description
Secondary dependent variables are accuracy (% correct) when comparing a neutral memory task to a stress condition.
Time Frame
Measured immediately during one hour fMRI
Title
Change in accuracy during executive function testing during fMRI
Description
Secondary dependent variables are accuracy (% correct) when comparing a neutral memory task to a stress condition.
Time Frame
Measured immediately during one hour fMRI
Title
Brain activation during memory testing during fMRI
Description
Group differences in brain activation provoked by the memory stress condition will be assessed using brain maps that compare block-average BOLD signal for resting vs neutral task, resting vs stress task, neutral vs stress task.
Time Frame
Measured immediately during one hour fMRI
Title
Brain activation during executive function testing during fMRI
Description
Group differences in brain activation provoked by the executive function stress condition will be assessed using brain maps that compare block-average BOLD signal for resting vs neutral task, resting vs stress task, neutral vs stress task.
Time Frame
Measured immediately during one hour fMRI
Title
Change in gait performance provoked by memory dual tasking
Description
The secondary dependent variable will be DTEmob = (Dual task[mobility score] - Single Task[mobility score] / Single task [mobility score]. For both memory and executive tasks, the mobility measure in the DTEmob calculation will be gait speed.
Time Frame
Measured immediately during one hour gait session
Title
Change in gait performance provoked by executive function dual tasking
Description
The secondary dependent variable will be DTEmob = (Dual task[mobility score] - Single Task[mobility score] / Single task [mobility score]. For both memory and executive tasks, the mobility measure in the DTEmob calculation will be gait speed.
Time Frame
Measured immediately during one hour gait session

10. Eligibility

Sex
All
Minimum Age & Unit of Time
58 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Able to walk 2 minutes without assistive device or assistance from another person Cognitive function within normal limits Exclusion Criteria: Unable to undergo MRI Left handed Red/Green Color Blind Severe vision impairments Diagnosis of Alzheimer's Disease or other dementia/memory problem
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Heather Whitson, MD, MHS
Organizational Affiliation
Duke University Aging Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Duke University Medical Center
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27710
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The Cognitive Resilience Study

We'll reach out to this number within 24 hrs